Cambridge, MA · Founded 2021 · Privately Held (backing)
Developer of a novel device-based technology designed to focus on developing innovative treatments for Chronic Ocular Surface Pain (COSP). EyeCool Therapeutics is based in Cambridge, MA and was founded in 2021. It has raised $12.5 million.
Last price · $/share
—
Implied valuation
—
Total raised
$12.5M
Last round
—
Cap table — not yet on record
EyeCool Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EyeCool Therapeutics with a free account
·Watch EyeCool Therapeutics: the Monday email on marks, rounds and moves
